Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2014 (2014), Article ID 285906, 9 pages
http://dx.doi.org/10.1155/2014/285906
Research Article

Expression of the Matrix Metalloproteases 2, 14, 24, and 25 and Tissue Inhibitor 3 as Potential Molecular Markers in Advanced Human Gastric Cancer

1Biomedical Sciences Doctoral Program, Biomedical Research Center, University of Veracruz, 91190 Xalapa, Veracruz, Mexico
2Institute of Public Health, University of Veracruz, 91190 Xalapa, Veracruz, Mexico
3Public Health Master Program, University of Veracruz, 91190 Xalapa, Veracruz, Mexico
4Dr. Miguel Dorantes Mesa Hospital, 91130 Xalapa, Veracruz, Mexico
5Medical-Biological Research Institute, University of Veracruz, 91700 Veracruz, Veracruz, Mexico

Received 9 February 2013; Accepted 27 November 2013; Published 11 February 2014

Academic Editor: Stamatios Theocharis

Copyright © 2014 Sol de la Peña et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Brenner, D. Rothenbacher, and V. Arndt, “Epidemiology of stomach cancer,” Methods in Molecular Biology, vol. 472, pp. 467–477, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. A. C. de Vries, G. A. Meijer, C. W. N. Looman et al., “Epidemiological trends of pre-malignant gastric lesions: a long-term nationwide study in the Netherlands,” Gut, vol. 56, no. 12, pp. 1665–1670, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. S. I. Meireles, E. B. Cristo, A. F. Carvalho et al., “Molecular classifiers for gastric cancer and nonmalignant diseases of the gastric mucosa,” Cancer Research, vol. 64, no. 4, pp. 1255–1265, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Correa, C. Cuello, E. Duque et al., “Gastric cancer in Colombia. III. Natural history of precursor lesions,” Journal of the National Cancer Institute, vol. 57, no. 5, pp. 1027–1035, 1976. View at Google Scholar · View at Scopus
  5. P. Correa, “The biological model of gastric carcinogenesis,” IARC Scientific Publications, no. 157, pp. 301–310, 2004. View at Google Scholar · View at Scopus
  6. R. M. Genta and M. Rugge, “Assessing risks for gastric cancer: new tools for pathologists,” World Journal of Gastroenterology, vol. 12, no. 35, pp. 5622–5627, 2006. View at Google Scholar · View at Scopus
  7. H. Moller, E. Heseltine, and H. Vainio, “Working group report on schistosomes, liver flukes and Helicobacter pylori,” International Journal of Cancer, vol. 60, no. 5, pp. 587–589, 1995. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Kim, H. J. Kim, B. Y. Choi et al., “Identification of potential serum biomarkers for gastric cancer by a novel computational method, multiple normal tissues corrected differential analysis,” Clinica Chimica Acta, vol. 413, no. 3-4, pp. 428–433, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Yoshikawa, A. Tsuburaya, O. Kobayashi, M. Sairenji, and Y. Miyagi, “Protein levels of tissue inhibitor of metalloproteinase-1 in tumor extracts as a marker for prognosis and recurrence in patients with gastric cancer,” Gastric Cancer, vol. 9, no. 2, pp. 106–113, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. B. J. Dicken, D. L. Bigam, C. Cass, J. R. Mackey, A. A. Joy, and S. M. Hamilton, “Gastric adenocarcinoma: review and considerations for future directions,” Annals of Surgery, vol. 241, no. 1, pp. 27–39, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. J. P. Baren, G. D. Stewart, A. Stokes et al., “mRNA profiling of the cancer degradome in oesophago-gastric adenocarcinoma,” British Journal of Cancer, vol. 107, pp. 143–149, 2012. View at Google Scholar
  12. Y. Kosaka, K. Mimori, T. Fukagawa et al., “Clinical significance of molecular detection of matrix metalloproteinase-1 in bone marrow and peripheral blood in patients with gastric cancer,” Annals of Surgical Oncology, vol. 19, supplement 3, pp. S430–S437, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. A. B. Benson, “Advanced gastric cancer: an update and future directions,” Gastrointestinal Cancer Research, vol. 2, pp. 47–53, 2008. View at Google Scholar
  14. S. A. Bustin, V. Benes, T. Nolan, and M. W. Pfaffl, “Quantitative real-time RT-PCR: a perspective,” Journal of Molecular Endocrinology, vol. 34, no. 3, pp. 597–601, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Y. Wu, M. S. Wu, Y. J. Chen et al., “Clinicopathological significance of MMP-2 and TIMP-2 genotypes in gastric cancer,” European Journal of Cancer, vol. 43, no. 4, pp. 799–808, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Egeblad and Z. Werb, “New functions for the matrix metalloproteinases in cancer progression,” Nature Reviews Cancer, vol. 2, no. 3, pp. 161–174, 2002. View at Google Scholar · View at Scopus
  17. A. Elnemr, Y. Yonemura, E. Bandou et al., “Expression of collagenase-3 (matrix metalloproteinase-13) in human gastric cancer,” Gastric Cancer, vol. 6, no. 1, pp. 30–38, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. R. P. Verma and C. Hansch, “Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs,” Bioorganic and Medicinal Chemistry, vol. 15, no. 6, pp. 2223–2268, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. M. P. Vincenti and C. E. Brinckerhoff, “Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors,” Arthritis Research, vol. 4, no. 3, pp. 157–164, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Page-McCaw, A. J. Ewald, and Z. Werb, “Matrix metalloproteinases and the regulation of tissue remodelling,” Nature Reviews Molecular Cell Biology, vol. 8, no. 3, pp. 221–233, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. A. H. Baker, D. R. Edwards, and G. Murphy, “Metalloproteinase inhibitors: biological actions and therapeutic opportunities,” Journal of Cell Science, vol. 115, no. 19, pp. 3719–3727, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. R. K. Nuttall, C. L. Sampieri, C. J. Pennington, S. E. Gill, G. A. Schultz, and D. R. Edwards, “Expression analysis of the entire MMP and TIMP gene families during mouse tissue development,” The FEBS Letters, vol. 563, no. 1–3, pp. 129–134, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. H. Alakus, G. Grass, J. K. Hennecken et al., “Clinicopathological significance of MMP-2 and its specific inhibitor TIMP-2 in gastric cancer,” Histology and Histopathology, vol. 23, no. 8, pp. 917–923, 2008. View at Google Scholar · View at Scopus
  24. T. Yoshikawa, A. Tsuburaya, O. Kobayashi et al., “Intratumoral concentrations of tissue inhibitor of matrix metalloproteinase 1 in patients with gastric carcinoma a new biomarker for invasion and its impact on survival,” Cancer, vol. 91, pp. 1739–1744, 2001. View at Google Scholar
  25. Z. Y. Wu, J. H. Li, W. H. Zhan, and Y. L. He, “Lymp node micrometastasis and its correlation with MMP-2 expression in gastric carcinoma,” World Journal of Gastroenterology, vol. 12, no. 19, pp. 2941–2944, 2006. View at Google Scholar · View at Scopus
  26. T. Inoue, M. Yashiro, S. Nishimura et al., “Matrix metalloproteinase-1 expression is a prognostic factor for patients with advanced gastric cancer,” International Journal of Molecular Medicine, vol. 4, no. 1, pp. 73–77, 1999. View at Google Scholar · View at Scopus
  27. C. F. M. Sier, F. J. G. M. Kubben, S. Ganesh et al., “Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma,” British Journal of Cancer, vol. 74, no. 3, pp. 413–417, 1996. View at Google Scholar · View at Scopus
  28. E. Bando, Y. Yonemura, Y. Endou et al., “Immunohistochemical study of MT-MMP tissue status in gastric carcinoma and correlation with survival analyzed by univariate and multivariate analysis,” Oncology Reports, vol. 5, no. 6, pp. 1483–1488, 1998. View at Google Scholar · View at Scopus
  29. S. de la Peña, C. Sampieri, and K. León-Córdoba, “Matrix metalloproteases as molecular markers in gastric cancer,” Medicina Clinica, vol. 134, no. 3, pp. 123–126, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. P. J. Bergin, E. Anders, W. Sicheng et al., “Increase production of matrix metalloproteinases in Helicobacter pylori-associated human gastritis,” Helicobacter, vol. 9, no. 3, pp. 201–210, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. H. I. Rautelin, A. M. Oksanen, L. I. Veijola et al., “Enhanced systemic matrix metalloproteinase response in helicobacter pylori gastritis,” Annals of Medicine, vol. 41, no. 3, pp. 208–215, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. R. K. Nuttall, C. J. Pennington, J. Taplin et al., “Elevated membrane-type matrix metalloproteinases in gliomas revealed by profiling proteases and inhibitors in human cancer cells,” Molecular Cancer Research, vol. 1, no. 5, pp. 333–345, 2003. View at Google Scholar · View at Scopus
  33. Y. Itoh, A. Ito, K. Iwata, K. Tanzawa, Y. Mori, and H. Nagase, “Plasma membrane-bound tissue inhibitor of metalloproteinases (TIMP)-2 specifically inhibits matrix metalloproteinase 2 (gelatinase A) activated on the cell surface,” Journal of Biological Chemistry, vol. 273, no. 38, pp. 24360–24367, 1998. View at Publisher · View at Google Scholar · View at Scopus
  34. Q. Sun, C. R. Weber, A. Sohail et al., “MMP25 (MT6-MMP) is highly expressed in human colon cancer, promotes tumor growth, and exhibits unique biochemical properties,” Journal of Biological Chemistry, vol. 282, no. 30, pp. 21998–22010, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. C. L. Sampieri, S. de la Peña, M. Ochoa-Lara, R. Zenteno-Cuevas, and K. León-Córdoba, “Expression of matrix metalloproteinases 2 and 9 in human gastric cancer and superficial gastritis,” World Journal of Gastroenterology, vol. 16, no. 12, pp. 1500–1505, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. G. I. Murray, M. E. Duncan, E. Arbuckle, W. T. Melvin, and J. E. Fothergill, “Matrix metalloproteinases and their inhibitors in gastric cancer,” Gut, vol. 43, no. 6, pp. 791–797, 1998. View at Google Scholar · View at Scopus
  37. H. Allgayer, R. Babic, K. U. Grützner et al., “Tumor-associated proteases and inhibitors in gastric cancer: analysis of prognostic impact and individual risk protease patterns,” Clinical and Experimental Metastasis, vol. 16, no. 1, pp. 62–73, 1998. View at Publisher · View at Google Scholar · View at Scopus
  38. S. P. Mönig, S. E. Baldus, J. K. Hennecken et al., “Expression of MMP-2 is associated with progression and lymph node metastasis of gastric carcinoma,” Histopathology, vol. 39, no. 6, pp. 597–602, 2001. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Kabashima, Y. Maehara, Y. Kakeji, H. Baba, T. Koga, and K. Sugimachi, “Clinicopathological features and overexpression of matrix metalloproteinases in intramucosal gastric carcinoma with lymph node metastasis,” Clinical Cancer Research, vol. 6, no. 9, pp. 3581–3584, 2000. View at Google Scholar · View at Scopus
  40. J. Mrena, J. P. Wiksten, S. Nordling, A. Kokkola, A. Ristimäki, and C. Haglund, “MMP-2 but not MMP-9 associated with COX-2 and survival in gastric cancer,” Journal of Clinical Pathology, vol. 59, no. 6, pp. 618–623, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. Q. He, J. Chen, H. L. Lin, P. J. Hu, and M. H. Chen, “Expression of peroxisome proliferator-activated receptor γ, E-cadherin and matrix metalloproteinases-2 in gastric carcinoma and lymph node metastases,” Chinese Medical Journal, vol. 120, no. 17, pp. 1498–1504, 2007. View at Google Scholar · View at Scopus
  42. L. B. Wang, Z. N. Jiang, M. Y. Fan, C. Y. Xu, W. J. Chen, and J. G. Shen, “Changes of histology and expression of MMP-2 and nm23-H1 in primary and metastatic gastric cancer,” World Journal of Gastroenterology, vol. 14, no. 10, pp. 1612–1616, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Mori, K. Mimori, T. Shiraishi et al., “Analysis of MT1-MMP and MMP2 expression in human gastric cancers,” International Journal of Cancer, vol. 74, pp. 316–321, 1997. View at Google Scholar
  44. P. Gu, X. Xing, M. Tänzer et al., “Frequent loss of TIMP-3 expression in progression of esophageal and gastric adenocarcinomas,” Neoplasia, vol. 10, no. 6, pp. 563–572, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. T. Yokoyama, H. Nakamura, Y. Otani et al., “Differences between scirrhous and non-scirrhous human gastric carcinomas from the aspect of proMMP-2 activation regulated by TIMP-3,” Clinical and Experimental Metastasis, vol. 21, no. 3, pp. 223–233, 2004. View at Publisher · View at Google Scholar · View at Scopus
  46. T. Miyazaki, H. Kato, M. Nakajima et al., “An immunohistochemical study of TIMP-3 expression in oesophageal squamous cell carcinoma,” British Journal of Cancer, vol. 91, no. 8, pp. 1556–1560, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. C. Caenazzo, M. Onisto, L. Sartor et al., “Augmented membrane type 1 matrix metalloproteinase (MT1-MMP): MMP-2 messenger RNA ratio in gastric carcinomas with poor prognosis,” Clinical Cancer Research, vol. 4, no. 9, pp. 2179–2186, 1998. View at Google Scholar · View at Scopus
  48. S. Zhang, L. Li, J. Y. Lin, and H. Lin, “Imbalance between expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in invasiveness and metastasis of human gastric carcinoma,” World Journal of Gastroenterology, vol. 9, no. 5, pp. 899–904, 2003. View at Google Scholar · View at Scopus